555 related articles for article (PubMed ID: 30635846)
1. Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm.
Cysique LA; Brew BJ
J Neurovirol; 2019 Oct; 25(5):710-721. PubMed ID: 30635846
[TBL] [Abstract][Full Text] [Related]
2. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
Rosenthal J; Tyor W
J Neurovirol; 2019 Oct; 25(5):673-685. PubMed ID: 30868422
[TBL] [Abstract][Full Text] [Related]
3. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.
Gorelick PB; Scuteri A; Black SE; Decarli C; Greenberg SM; Iadecola C; Launer LJ; Laurent S; Lopez OL; Nyenhuis D; Petersen RC; Schneider JA; Tzourio C; Arnett DK; Bennett DA; Chui HC; Higashida RT; Lindquist R; Nilsson PM; Roman GC; Sellke FW; Seshadri S;
Stroke; 2011 Sep; 42(9):2672-713. PubMed ID: 21778438
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychological profiles of vascular disease and risk of dementia: implications for defining vascular cognitive impairment no dementia (VCI-ND).
Stephan BCM; Minett T; Muniz-Terrera G; Harrison SL; Matthews FE; Brayne C
Age Ageing; 2017 Sep; 46(5):755-760. PubMed ID: 28203692
[TBL] [Abstract][Full Text] [Related]
5. The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease.
Rubin LH; Sundermann EE; Moore DJ
J Neurovirol; 2019 Oct; 25(5):661-672. PubMed ID: 30671777
[TBL] [Abstract][Full Text] [Related]
6. Current perspectives on prevention of vascular cognitive impairment and promotion of vascular brain health.
Kalaria RN; Akinyemi RO; Paddick SM; Ihara M
Expert Rev Neurother; 2024; 24(1):25-44. PubMed ID: 37916306
[TBL] [Abstract][Full Text] [Related]
7. Clinical presentations and epidemiology of vascular dementia.
Smith EE
Clin Sci (Lond); 2017 Jun; 131(11):1059-1068. PubMed ID: 28515342
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological assessment and cerebral vascular disease: the new standards.
Godefroy O; ; Leclercq C; Bugnicourt JM; Roussel M; Moroni C; Quaglino V; Beaunieux H; Taillia H; Nédélec-Ciceri C; Bonnin C; Thomas-Anterion C; Varvat J; Aboulafia-Brakha T; Assal F
Rev Neurol (Paris); 2013 Oct; 169(10):779-85. PubMed ID: 23999023
[TBL] [Abstract][Full Text] [Related]
9. Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo.
Helman AM; Murphy MP
Biochim Biophys Acta; 2016 May; 1862(5):975-82. PubMed ID: 26704178
[TBL] [Abstract][Full Text] [Related]
10. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH
J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421
[TBL] [Abstract][Full Text] [Related]
11. Rivastigmine for vascular cognitive impairment.
Birks J; McGuinness B; Craig D
Cochrane Database Syst Rev; 2013 May; (5):CD004744. PubMed ID: 23728651
[TBL] [Abstract][Full Text] [Related]
12. Vascular Cognitive Impairment (VCI).
Rundek T; Tolea M; Ariko T; Fagerli EA; Camargo CJ
Neurotherapeutics; 2022 Jan; 19(1):68-88. PubMed ID: 34939171
[TBL] [Abstract][Full Text] [Related]
13. Aging and Apolipoprotein E in HIV Infection.
Geffin R; McCarthy M
J Neurovirol; 2018 Oct; 24(5):529-548. PubMed ID: 29987582
[TBL] [Abstract][Full Text] [Related]
14. Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study.
Rockwood K; Moorhouse PK; Song X; MacKnight C; Gauthier S; Kertesz A; Montgomery P; Black S; Hogan DB; Guzman A; Bouchard R; Feldman H;
J Neurol Sci; 2007 Jan; 252(2):106-12. PubMed ID: 17189642
[TBL] [Abstract][Full Text] [Related]
15. The current situation on vascular cognitive impairment after ischemic stroke in Changsha.
Tu Q; Ding B; Yang X; Bai S; Tu J; Liu X; Wang R; Tao J; Jin H; Wang Y; Tang X
Arch Gerontol Geriatr; 2014; 58(2):236-47. PubMed ID: 24148887
[TBL] [Abstract][Full Text] [Related]
16. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia.
Román GC; Sachdev P; Royall DR; Bullock RA; Orgogozo JM; López-Pousa S; Arizaga R; Wallin A
J Neurol Sci; 2004 Nov; 226(1-2):81-7. PubMed ID: 15537526
[TBL] [Abstract][Full Text] [Related]
17. CROI 2019: neurologic complications of HIV disease.
Ances BM; Letendre SL
Top Antivir Med; 2019 Apr; 27(1):26-33. PubMed ID: 31137000
[TBL] [Abstract][Full Text] [Related]
18. Progression in Vascular Cognitive Impairment: Pathogenesis, Neuroimaging Evaluation, and Treatment.
Zhang X; Su J; Gao C; Ni W; Gao X; Li Y; Zhang J; Lei Y; Gu Y
Cell Transplant; 2019 Jan; 28(1):18-25. PubMed ID: 30488737
[TBL] [Abstract][Full Text] [Related]
19. Vascular cognitive impairment and vascular dementia.
Rockwood K
J Neurol Sci; 2002 Nov; 203-204():23-7. PubMed ID: 12417352
[TBL] [Abstract][Full Text] [Related]
20. Vascular cognitive impairment and dementia expenditures: 7-year inpatient cost description in community dwellers.
Ramos-Estebanez C; Moral-Arce I; Rojo F; Gonzalez-Macias J; Hernandez JL
Postgrad Med; 2012 Sep; 124(5):91-100. PubMed ID: 23095429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
